Trump's Impact on Eli Lilly

Order byBest matchMost fresh

Trump, drug prices

Trump's order on US drug prices: What's in it, and will it work?

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details and long-term effects are far from clear. Citing figures that patients in other countries pay much less than Americans for pharmaceuticals, Trump said he would order drug companies to reduce their prices inside the US.

· 23h

One estimate of the profit hit from Trump's executive order on drug pricing

SHINE · 8h

Biotech firms assess the impact of Trump's new order on drug pricing

· 1d

With No Real Policy, Trump Asks Drugmakers to Lower U.S. Prices

President Trump on Monday signed an executive order asking drugmakers to voluntarily reduce the prices of key medicines in the United States.

· 10h

Australia says it will not compromise on drug subsidies as Trump reviews US prices

· 1d

Trump's Drug Pricing Order Delivers Blow to Pharmacy Benefit Managers

STAT13d

Assessing the impact of Trump’s first 100 days on science and health policy

STAT editors and reporters review the widespread impact of grant cuts, layoffs and policy changes — and also discuss recent drug launches.

USA Today13d

Eli Lilly CEO says tariffs are not the answer, urges Trump to move fast on trade deals

Eli Lilly CEO Dave Ricks urged the Trump administration to move fast on foreign trade ... But he warned an expansion on tariffs or retaliatory tariffs would have a negative impact on not just Lilly but the entire pharmaceutical industry.

10d

Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?

Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Indeed, shares of the three biggest pharmaceutical companies based on market cap -- AbbVie (NYSE: ABBV),

Daily Journal3d

Hoosier business executives say to voice tariff concerns, find alternative trade pathways

Business leaders from major Hoosier companies say they are trying to navigate the uncertain trade environment created by President Donald Trump’s fluctuating tariff policy by exploring alternative options and being vocal about problems when they arise.